Martin Shkreli, the Turing Pharmaceuticals executive notorious for raising drug prices by obscene amounts (most notably raising the price of Daraprim, a drug used to treat AIDS patients, from $13.50/pill to $750/pill) and being an in-your-face asshole about it, has been arrested on federal securities fraud charges:
Martin Shkreli, a pharmaceutical entrepreneur and former hedge fund manager who has been widely criticized for drug price gouging, was arrested Thursday morning by the federal authorities.
The investigation, in which Mr. Shkreli has been charged with securities fraud, is related to his time as a hedge fund manager and running the biopharmaceutical company Retrophin — not the price-gouging controversy that has swirled around him.
The federal charges are believed to parallel a civil lawsuit filed against Mr. Shkreli in August by Retrophin, whose board ousted Mr. Shkreli as chief executive in September 2014. In its lawsuit, Retrophin accused Mr. Shkreli of having used the company as a kind of personal piggy bank to help pay off upset investors who lost money at the hedge fund MSMB. Among the ways he did this, the lawsuit says, was by hiring some of these investors as sham consultants to Retrophin.
Big Pharma’s Big Jerk, as I like to call Shkreli, is not being charged over raising drug prices, but over allegations that he used Retrophin, a pharmaceutical company he was once the CEO for, as a piggy bank to pay off investors who lost money at MSMB, the hedge fund Shkreli co-founded. In addition to the criminal charges against Big Pharma’s Big Jerk, there’s an ongoing civil suit into the matter.
This couldn’t happen to a more deserving person if you asked for it.